{"name": "Zyngenia",
 "permalink": "zyngenia",
 "crunchbase_url": "http://www.crunchbase.com/company/zyngenia",
 "homepage_url": "http://www.zyngenia.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2008,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@zyngenia.com",
 "phone_number": "",
 "description": "",
 "created_at": "Wed Feb 03 03:25:46 UTC 2010",
 "updated_at": "Fri Sep 10 03:09:42 UTC 2010",
 "overview": "\u003Cp\u003EFounded in 2008, Zyngenia, Inc. is a privately held biotherapeutics company focused on the development of the next-generation of antibody-derived  drugs. The company uses proprietary technology to enable the development of singular molecular entities that address two or more targets, by combining the activity of two or more biologic therapies into one protein (known as a Zybody\u00e2\u201e\u00a2). In addition, the technology will also be applied to drug targets that previously have not been reachable through the use of traditional, single specificity, monoclonal antibodies.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[100,
       106],
      "assets/images/resized/0007/5863/75863v1-max-150x150.jpg"],
     [[100,
       106],
      "assets/images/resized/0007/5863/75863v1-max-250x250.jpg"],
     [[100,
       106],
      "assets/images/resized/0007/5863/75863v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Peter",
      "last_name": "A. Kiener",
      "permalink": "peter-a-kiener",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$25M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020100908e699000ul\u0026r=Rss\u0026s=DJFVW",
    "source_description": "New Enterprise Associates Extends Zyngenia Series A To $25M  ",
    "raised_amount": 25000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 9,
    "funded_day": 9,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "21 Firstfield Road",
    "address2": "Suite 200",
    "zip_code": "20878",
    "city": "Gaithersburg",
    "state_code": "MD",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        80],
       "assets/images/resized/0007/5862/75862v1-max-150x150.jpg"],
      [[250,
        134],
       "assets/images/resized/0007/5862/75862v1-max-250x250.jpg"],
      [[450,
        242],
       "assets/images/resized/0007/5862/75862v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}